Navigation Links
Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial

sal hormone therapy and resulted in significantly fewer women using these products," said Isaac Cohen, CEO of Bionovo. "For this reason, it is important for us to find safer alternatives for treating menopausal symptoms. The favorable dose response trend signals that MF101 may become a clear alternative to traditional postmenopausal hormone therapy for relief of vasomotor symptoms. We are excited by the prospect of moving forward with the development of a product that could potentially have such broad reach and positively affect the quality of life for millions of women and their loved ones. This first Phase 2 trial conducted by Bionovo serves as a proof of our drug development strategy and we look forward to advancing MF101 into registration trials."

About MF101

MF101 is an estrogen receptor (ER) beta selective drug developed as an alternative to postmenopausal hormone products currently on the market, which are both ER beta and ER alpha agonists that have been shown to increase the risk for breast and uterine cancers. It has been shown that the increased risk of breast and uterine cancers is associated with ER alpha activation and that ER beta blocks the growth promoting effects on breast cancer cells. Bionovo recognized the opportunity to commercialize a product that would be equally effective, with an improved safety profile compared to traditional hormone therapy. The clinical trial results have been evaluated by an independent Data and Safety Monitoring Board and the drug candidate has passed through a standard two-phase examination for safety.

Bionovo, Inc.

Bionovo is a drug development company focusing on the discovery of novel pharmaceutical agents for cancer and women's health. The company has two drugs in clinical testing. MF101 has completed Phase 2 for quality of life conditions associated with menopause, and BZL101 is in Phase 1/2 for the treatment of advanced breast cancer. The company has an additional pipeline of drugs in
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:6/2/2015)...  ErgoNurse, the leader in bedside safety management solutions, and ... the United States , have formalized a partnership ... skilled nursing markets. ... Thousands of healthcare professionals in ... of the ErgoNurse products to stop unnecessarily utilizing their backs ...
(Date:6/2/2015)... announced today they are expanding their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
(Date:6/2/2015)... Today AmerisourceBergen, a global healthcare solutions leader, ... Olive Branch, MS ; ... . The facilities will operate within AmerisourceBergen,s existing ... increase supply chain efficiency and enhance patient care. ... ongoing investments, more than $1 billion over the last ...
Breaking Medicine Technology:ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4AmerisourceBergen to Build Three New Distribution Centers 2
... 1 Merriman Curhan Ford Group, Inc. (Nasdaq: ... Therapeutics, Inc. in the recent merger with Raptor Pharmaceuticals ... company is named "Raptor Pharmaceutical Corp." and commenced trading ... under the ticker symbol "RPTP." , Further details on ...
... 1 Ocular Therapeutix, Inc. announced today the expansion ... Mr. Daniel Myers and Mr. Bernard Haffey. , Mr. ... Alimera Sciences, Inc., a biopharmaceutical company that is developing ... Alimera has raised venture funding totaling approximately $90M. ...
Cached Medicine Technology:Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp. 2Ocular Therapeutix, Inc. Appoints Two New Board Members 2
(Date:6/2/2015)... (PRWEB) June 02, 2015 April 8th, ... music venue into Durkin Entertainment’s “RockNRolla Movie Awards” EcoLuxe ... Bend, that gathered some of the world’s top providers ... The event was organized by Debbie Durkin, Los Angeles’ ... film, the EcoLuxe Lounge is a premier red carpet ...
(Date:6/2/2015)... On Wednesday, May 27, 2015, professional driver, Brian Smith, drove ... 207.9 mph. In the process, Hennessey’s potent pony car ... mark. Jay Leno was on hand to witness the ... Garage, which will air on CNBC later this year. , ... oval at the Continental Tire Proving Grounds located in Uvalde, ...
(Date:6/2/2015)... Orlando, FL (PRWEB) June 02, 2015 ... can enjoy quality care in a more convenient location ... Publix in Partin Village Plaza, 2310 E. Irlo Bronson ... location is located less than a mile away from ... with warm décor, more spacious patient areas with digital ...
(Date:6/2/2015)... June 02, 2015 The 3TVPhoenix contest, conducted ... watch the station’s 6:00 a.m. Good Morning Arizona program for ... the station’s Facebook page. , Lisa Allen of ... She plans to apply the monthly $1,000 prize to ... a stay-at-home mom, expressed her surprise and gratitude at winning, ...
(Date:6/2/2015)... The term “Augmented Reality” was coined ... on the real world. Since then many promising technologies ... a map of the vasculature on the surface of ... , AccuVein, the leader in vein visualization, exemplifies this ... and such widespread adoption of its AccuVein AV400 devices ...
Breaking Medicine News(10 mins):Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:Coast Dental Office Opening In Kissimmee with Expanded Technology 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2
... March 15 Quantros, a leading healthcare software and services provider of data management, decision support analytics, and clinical business intelligence solutions today ... ... , ... ...
... ... that builds open source platforms and develops advanced research solutions, has ... totaling more than $600,000 to focus research efforts on developing approach-specific, ... is to work towards an interactive simulator that replicates future neurosurgery ...
... traditional screening tests for potential anti-cancer drugs, scientists ... technique that more closely simulates the real-world conditions ... normal cells. Because these neighboring cells key ... microenvironment" can alter the effectiveness of anti-cancer ...
... take the place of a good clinical exam, study finds ... symptoms, but 70 percent of able-bodied professional and collegiate hockey ... MRIs. , "This study was done to see if abnormal ... Dr. Matthew Silvis, an assistant professor in the department of ...
... levels below currently recommended levels did not ... cardiovascular disease events in adults with type 2 diabetes ... events, according to new results from the landmark Action ... Similarly, treating multiple blood lipids with combination drug therapy ...
... MARCH 13, 2010 The announcement of a new ... Artery Bypass Surgery for Effectiveness of Left Main Revascularization), ... graft surgery in patients with left main coronary artery ... Paradigms," a symposium presented by the Cardiovascular Research Foundation. ...
Cached Medicine News:Health News:Quantros Announces Support for Oracle's Enterprise Healthcare Analytics (EHA) Solution to Improve the Quality and Safety of Patient Care 2Health News:Quantros Announces Support for Oracle's Enterprise Healthcare Analytics (EHA) Solution to Improve the Quality and Safety of Patient Care 3Health News:Quantros Announces Support for Oracle's Enterprise Healthcare Analytics (EHA) Solution to Improve the Quality and Safety of Patient Care 4Health News:National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation 2Health News:National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation 3Health News:New cancer drug screening technique more closely mirrors reality 2Health News:New cancer drug screening technique more closely mirrors reality 3Health News:Scans May Be Misleading for Hockey Players 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 4Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 5Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 6Health News:EXCEL trial will determine safety and efficacy of drug-eluting stents vs. bypass surgery 2
... marketing software enables the efficient capture of ... also has many built-in time saving and ... of name fields and numerous user definable ... data input. The pre-defined options in the ...
... Management software- RLISYS provides ... Software, Support, and Training ... Optometry, Ophthalmology, and Opticianry- ... operations, allowing you to ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
The SF-3000 automated hematology analyzer can provide accurate and precise 23-parameter hematolgy results including a fully automated WBC 5-part differential from a compact space-save design....
Medicine Products: